The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Optic pathway gliomas in neurofibromatosis‐1: Controversies and recommendations
Open accessAbstract
Optic pathway glioma (OPG), seen in 15% to 20% of individuals with neurofibromatosis type 1 (NF1), account for significant morbidity in young children with NF1. Overwhelmingly a tumor of children younger than 7 years, OPG may present in individuals with NF1 at any age. Although many OPG may remain indolent and never cause signs or symptoms, others lead to vision loss, proptosis, or precocious puberty. Because the natural history and treatment of NF1‐associated OPG is different from that of sporadic OPG in individuals without NF1, a task force composed of basic scientists and clinical researchers was assembled in 1997 to propose a set of guidelines for the diagnosis and management of NF1‐associated OPG. This new review highlights advances in our understanding of the pathophysiology and clinical behavior of these tumors made over the last 10 years. Controversies in both the diagnosis and management of these tumors are examined. Finally, specific evidence‐based recommendations are proposed for clinicians caring for children with NF1. Ann Neurol 2007;61:189–198
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,397
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
GEFs and GAPs: Critical Elements in the Control of Small G Proteins
Bos, J. L., Rehmann, H., & Wittinghofer, A. (2007) · Cell · doi:10.1016/j.cell.2007.05.018 · Cited by 1,903
Cancerous stem cells can arise from pediatric brain tumors
Hemmati, H. D., Nakano, I., Lazareff, J. A., Masterman-Smith, M., Geschwind, D. H., Bronner-Fraser, M., & Kornblum, H. I. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2036535100 · Cited by 1,817
The role of microglia and macrophages in glioma maintenance and progression
Hambardzumyan, D., Gutmann, D. H., & Kettenmann, H. (2016) · Nature Neuroscience · doi:10.1038/nn.4185 · Cited by 1,683
Self-citationLonser, R. R., Glenn, G. M., Walther, M., Chew, E. Y., Libutti, S. K., Linehan, W. M., & Oldfield, E. H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13643-4 · Cited by 1,600
The WHO classification of tumors of the nervous system
Kleihues, P., Louis, D. N., Scheithauer, B. W., Rorke, L. B., Reifenberger, G., Burger, P. C., & Cavenee, W. K. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.3.215 · Cited by 1,547
Type 1 Neurofibromatosis Gene: Identification of a Large Transcript Disrupted in Three NF1 Patients
Wallace, M. R., Marchuk, D. A., Andersen, L. B., Letcher, R., Odeh, H. M., Saulino, A. M., Fountain, J. W., Brereton, A., Nicholson, J., Mitchell, A. L., et al. (1990) · Science · doi:10.1126/science.2134734 · Cited by 1,475
The neurofibromatosis type 1 gene encodes a protein related to GAP
Xu, G., O'Connell, P., Viskochil, D., Cawthon, R., Robertson, M., Culver, M., Dunn, D., Stevens, J., Gesteland, R., White, R., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90024-9 · Cited by 1,095
Cawthon, R. M., Weiss, R., Xu, G., Viskochil, D., Culver, M., Stevens, J., Robertson, M., Dunn, D., Gesteland, R., O'Connell, P., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90253-b · Cited by 1,094
Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus
Viskochil, D., Buchberg, A. M., Xu, G., Cawthon, R. M., Stevens, J., Wolff, R. K., Culver, M., Carey, J. C., Copeland, N. G., Jenkins, N. A., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90252-a · Cited by 1,082
Guidelines for the diagnosis and management of individuals with neurofibromatosis 1
Ferner, R. E., Huson, S. M., Thomas, N., Moss, C., Willshaw, H., Evans, D. G., Upadhyaya, M., Towers, R., Gleeson, M., Steiger, C., et al. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2006.045906 · Cited by 1,053
Self-citationJones, D. T. W., Kocialkowski, S., Liu, L., Pearson, D. M., Bäcklund, L. M., Ichimura, K., & Collins, V. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2097 · Cited by 944
The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins.
Ballester, R., Marchuk, D., Boguski, M., Saulino, A., Letcher, R., Wigler, M., & Collins, F. (1990) · Cell · doi:10.1016/0092-8674(90)90151-4 · Cited by 847
Tumour predisposition in mice heterozygous for a targeted mutation in Nf1
Jacks, T., Shih, T. S., Schmitt, E. M., Bronson, R. T., Bernards, A., & Weinberg, R. A. (1994) · Nature Genetics · doi:10.1038/ng0794-353 · Cited by 778
Yang, Z.-J., Ellis, T., Markant, S. L., Read, T.-A., Kessler, J. D., Bourboulas, M., Schüller, U., Machold, R., Fishell, G., Rowitch, D. H., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.07.003 · Cited by 698
Xu, G., Lin, B., Tanaka, K., Dunn, D., Wood, D., Gesteland, R., White, R., Weiss, R., & Tamanoi, F. (1990) · Cell · doi:10.1016/0092-8674(90)90149-9 · Cited by 681
Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients
Basu, T. N., Gutmann, D. H., Fletcher, J. A., Glover, T. W., Collins, F. S., & Downward, J. (1992) · Nature · doi:10.1038/356713a0 · Cited by 668
Self-citationProminin 1 marks intestinal stem cells that are susceptible to neoplastic transformation
Zhu, L., Gibson, P., Currle, D. S., Tong, Y., Richardson, R. J., Bayazitov, I. T., Poppleton, H., Zakharenko, S., Ellison, D. W., & Gilbertson, R. J. (2009) · Nature · doi:10.1038/nature07589 · Cited by 668
Schüller, U., Heine, V. M., Mao, J., Kho, A. T., Dillon, A. K., Han, Y.-G., Huillard, E., Sun, T., Ligon, A. H., Qian, Y., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.07.005 · Cited by 667
Brannan, C. I., Perkins, A. S., Vogel, K. S., Ratner, N., Nordlund, M. L., Reid, S. W., Buchberg, A. M., Jenkins, N. A., Parada, L. F., & Copeland, N. G. (1994) · Genes & Development · doi:10.1101/gad.8.9.1019 · Cited by 641
Packer, R. J., Ater, J., Allen, J., Phillips, P., Geyer, R., Nicholson, H. S., Jakacki, R., Kurczynski, E., Needle, M., Finlay, J., et al. (1997) · Journal of Neurosurgery · doi:10.3171/jns.1997.86.5.0747 · Cited by 636
Zhu, Y., Romero, M. I., Ghosh, P., Ye, Z., Charnay, P., Rushing, E. J., Marth, J. D., & Parada, L. F. (2001) · Genes & Development · doi:10.1101/gad.862101 · Cited by 604
The NF1 tumor suppressor critically regulates TSC2 and mTOR
Johannessen, C. M., Reczek, E. E., James, M. F., Brems, H., Legius, E., & Cichowski, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503224102 · Cited by 601
Bollag, G., Clapp, D. W., Shih, S., Adler, F., Zhang, Y. Y., Thompson, P., Lange, B. J., Freedman, M. H., McCormick, F., Jacks, T., et al. (1996) · Nature Genetics · doi:10.1038/ng0296-144 · Cited by 589
Epidemiology of neurofibromatosis type 1
Friedman, J. M. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990326)89:1<1::aid-ajmg3>3.0.co;2-8 · Cited by 577
Listernick, R., Charrow, J., Greenwald, M., & Mets, M. (1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(94)70122-9 · Cited by 548
Self-citationHuson, S. M., Compston, D. A., Clark, P., & Harper, P. S. (1989) · Journal of Medical Genetics · doi:10.1136/jmg.26.11.704 · Cited by 540
BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas
Pfister, S., Janzarik, W. G., Remke, M., Ernst, A., Werft, W., Becker, N., Toedt, G., Wittmann, A., Kratz, C., Olbrich, H., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33656 · Cited by 523
Listernick, R., Louis, D. N., Packer, R. J., & Gutmann, D. H. (1997) · Annals of Neurology · doi:10.1002/ana.410410204 · Cited by 478
Self-citationVerstappen, C. C. P., Heimans, J. J., Hoekman, K., & Postma, T. J. (2003) · Drugs · doi:10.2165/00003495-200363150-00003 · Cited by 456
Vogel, F. (1979) · Human Genetics · doi:10.1007/bf00284597 · Cited by 438
Sharif, S., Ferner, R., Birch, J. M., Gillespie, J. E., Gattamaneni, H. R., Baser, M. E., & Evans, D. G. R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.8349 · Cited by 377
Self-citationAutocrine Factors That Sustain Glioma Invasion and Paracrine Biology in the Brain Microenvironment
Hoelzinger, D. B., Demuth, T., & Berens, M. E. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm187 · Cited by 372
Upadhyaya, M., Huson, S. M., Davies, M., Thomas, N., Chuzhanova, N., Giovannini, S., Evans, D. G., Howard, E., Kerr, B., Griffiths, S., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/510781 · Cited by 362
Differential regulation of rasGAP and neurofibromatosis gene product activities
Bollag, G., & McCormick, F. (1991) · Nature · doi:10.1038/351576a0 · Cited by 341
Bajenaru, M. L., Zhu, Y., Hedrick, N. M., Donahoe, J., Parada, L. F., & Gutmann, D. H. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.14.5100-5113.2002 · Cited by 322
Self-citationGliomas of the optic nerve or chiasm: Outcome by patients' age, tumor site, and treatment
Alvord, E. C., & Lofton, S. (1988) · Journal of Neurosurgery · doi:10.3171/jns.1988.68.1.0085 · Cited by 308
Dasgupta, B., Yi, Y., Chen, D. Y., Weber, J. D., & Gutmann, D. H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4058 · Cited by 308
Self-citationOptic gliomas in children with neurofibromatosis type 1
Listernick, R., Charrow, J., Greenwald, M. J., & Esterly, N. B. (1989) · The Journal of Pediatrics · doi:10.1016/s0022-3476(89)80137-4 · Cited by 307
Self-citationEvans, D. G. R., Birch, J. M., Ramsden, R. T., Sharif, S., & Baser, M. E. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2005.036319 · Cited by 301
Guillamo, J.-S., Creange, A., Kalifa, C., Grill, J., Rodriguez, D., Doz, F., Barbarot, S., Zerah, M., Sanson, M., Bastuji-Garin, S., et al. (2003) · Brain · doi:10.1093/brain/awg016 · Cited by 295
Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity.
Bajenaru, M. L., Hernandez, M. R., Perry, A., Zhu, Y., Parada, L. F., Garbow, J. R., & Gutmann, D. H. (2003) · PubMed · Cited by 295
Self-citationOphthalmic manifestations of tuberous sclerosis: a population based study
Rowley, S. A. (2001) · British Journal of Ophthalmology · doi:10.1136/bjo.85.4.420 · Cited by 254
Neurofibromin regulates G protein–stimulated adenylyl cyclase activity
Tong, J., Hannan, F., Zhu, Y., Bernards, A., & Zhong, Y. (2002) · Nature Neuroscience · doi:10.1038/nn792 · Cited by 248
Morantz, R. A., Wood, G. W., Foster, M., Clark, M., & Gollahon, K. (1979) · Journal of Neurosurgery · doi:10.3171/jns.1979.50.3.0305 · Cited by 238
The pig eye as a novel model of glaucoma
Ruiz-Ederra, J., García, M., Hernández, M., Urcola, H., Hernández-Barbáchano, E., Araiz, J., & Vecino, E. (2005) · Experimental Eye Research · doi:10.1016/j.exer.2005.03.014 · Cited by 225
Purpose of Quality Standards for Infectious Diseases
Gross, P. A., Barrett, T. L., Dellinger, E. P., Krause, P. J., Martone, W. J., McGowan, J. E., Sweet, R. L., & Wenzel, R. P. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.3.421 · Cited by 223
Neurofibromatosis type 1 and optic pathway gliomas Follow-up of 54 patients
Thiagalingam, S. (2004) · Ophthalmology · doi:10.1016/j.ophtha.2003.06.008 · Cited by 219
Identification and characterization of the neurofibromatosis type 1 protein product.
DeClue, J. E., Cohen, B. D., & Lowy, D. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.9914 · Cited by 215
Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients
Maertens, O., Prenen, H., Debiec-Rychter, M., Wozniak, A., Sciot, R., Pauwels, P., De Wever, I., Vermeesch, J. R., de Raedt, T., De Paepe, A., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl016 · Cited by 214
Jacques, T. S., Swales, A., Brzozowski, M. J., Henriquez, N. V., Linehan, J. M., Mirzadeh, Z., O' Malley, C., Naumann, H., Alvarez‐Buylla, A., & Brandner, S. (2010) · The EMBO Journal · doi:10.1038/emboj.2009.327 · Cited by 214
Hegedus, B., Dasgupta, B., Shin, J. E., Emnett, R. J., Hart-Mahon, E. K., Elghazi, L., Bernal-Mizrachi, E., & Gutmann, D. H. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.07.008 · Cited by 212
Self-citationDaginakatte, G. C., & Gutmann, D. H. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm059 · Cited by 193
Self-citationVisual loss in children with neurofibromatosis type 1 and optic pathway gliomas
Balcer, L. J., Liu, G. T., Heller, G. D., Bilaniuk, L. T., Volpe, N. J., Galetta, S. L., Molloy, P. T., Phillips∥, P. C., Janss, A. J., Vaughn, S., et al. (2001) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(00)00852-7 · Cited by 191
Self-citationImmunohistological study of mononuclear cell infiltrate in malignant gliomas
Rossi, M. L., Hughes, J. T., Esiri, M. M., Coakham, H. B., & Brownell, D. B. (1987) · Acta Neuropathologica · doi:10.1007/bf00688191 · Cited by 190
Zhu, Y., Harada, T., Liu, L., Lush, M. E., Guignard, F., Harada, C., Burns, D. K., Bajenaru, M. L., Gutmann, D. H., & Parada, L. F. (2005) · Development · doi:10.1242/dev.02162 · Cited by 189
Self-citationNeurofibromatosis: Phenotype, Natural History and Pathogenesis
(2000) · Neurology · doi:10.1212/wnl.55.2.325 · Cited by 184
Dasgupta, B., Dugan, L. L., & Gutmann, D. H. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-26-08949.2003 · Cited by 177
Self-citationRegulatory Proteins of R-Ras, TC21/R-Ras2, and M-Ras/R-Ras3
Ohba, Y., Mochizuki, N., Yamashita, S., Chan, A. M., Schrader, J. W., Hattori, S., Nagashima, K., & Matsuda, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000981200 · Cited by 168
Pienta, K. J., McGregor, N., Axelrod, R., & Axelrod, D. E. (2008) · Translational Oncology · doi:10.1593/tlo.08178 · Cited by 168
Focal Ventricular Origin and Migration of Oligodendrocyte Precursors into the Chick Optic Nerve
Ono, K., Yasui, Y., Rutishauser, U., & Miller, R. H. (1997) · Neuron · doi:10.1016/s0896-6273(00)80939-3 · Cited by 167
Lau, N., Feldkamp, M. M., Roncari, L., Loehr, A. H., Shannon, P., Gutmann, D. H., & Guha, A. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.9.759 · Cited by 167
Self-citationLoss of neurofibromatosis 1 (NF1) gene expression in NF1‐associated pilocytic astrocytomas
Gutmann, D. H., Donahoe, J., Brown, T., James, C. D., & Perry, A. (2000) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2000.00258.x · Cited by 161
Self-citationPrecocious puberty in children with neurofibromatosis type 1
Habiby, R., Silverman, B., Listernick, R., & Charrow, J. (1995) · The Journal of Pediatrics · doi:10.1016/s0022-3476(95)70449-3 · Cited by 160
Self-citationOptic pathway gliomas in neurofibromatosis type 1: The effect of presenting symptoms on outcome
King, A. A., Listernick, R., Charrow, J., Piersall, L. D., & Gutmann, D. H. (2003) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.20211 · Cited by 151
Self-citationNeurofibromatosis type 1 and sporadic optic gliomas
Singhal, S. (2002) · Archives of Disease in Childhood · doi:10.1136/adc.87.1.65 · Cited by 141
Preclinical Cancer Therapy in a Mouse Model of Neurofibromatosis-1 Optic Glioma
Hegedűs, B., Banerjee, D., Yeh, T., Rothermich, S. Y., Perry, A., Rubin, J. B., Garbow, J. R., & Gutmann, D. H. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5916 · Cited by 140
Self-citationLate-onset optic pathway tumors in children with neurofibromatosis 1
Listernick, R., Ferner, R. E., Piersall, L. D., Sharif, S., Gutmann, D. H., & Charrow, J. (2004) · Neurology · doi:10.1212/01.wnl.0000144341.16830.01 · Cited by 134
Self-citationDasgupta, B., Yi, Y., Hegedűs, B., Weber, J. D., & Gutmann, D. H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1842 · Cited by 130
Self-citationDasgupta, B. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4693-04.2005 · Cited by 130
Warrington, N. M., Woerner, B. M., Daginakatte, G., Dasgupta, B., Perry, A., Gutmann, D. H., & Rubin, J. B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2220 · Cited by 125
Self-citationHannan, F., Ho, I. S., Tong, J. J., Zhu, Y., Nürnberg, P., & Zhong, Y. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl023 · Cited by 115
Daginakatte, G., Gianino, S. M., Zhao, N. W., Parsadanian, A. S., & Gutmann, D. H. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2506 · Cited by 114
Self-citationGlioma Formation in Neurofibromatosis 1 Reflects Preferential Activation of K-RAS in Astrocytes
Dasgupta, B., Li, W., Perry, A., & Gutmann, D. H. (2005) · Cancer Research · doi:10.1158/0008-5472.236.65.1 · Cited by 114
Self-citationVia, P. D., Opocher, E., Pinello, M. L., Calderone, M., Viscardi, E., Clementi, M., Battistella, P. A., Laverda, A. M., Dalt, L. D., & Perilongo, G. (2007) · Neuro-Oncology · doi:10.1215/15228517-2007-031 · Cited by 113
Outcomes of systematic screening for optic pathway tumors in children with Neurofibromatosis Type 1
Blazo, M., Lewis, R. A., Chintagumpala, M., Frazier, M., McCluggage, C. W., & Plon, S. E. (2004) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.20650 · Cited by 106
Fractionated stereotactic radiotherapy of optic pathway gliomas: Tolerance and long-term outcome
Combs, S. E., Schulz–Ertner, D., Moschos, D., Thilmann, C., Huber, P. E., & Debus, J. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.12.081 · Cited by 105
Neurofibromatosis type 1 — a model for nervous system tumour formation?
Rubin, J. B., & Gutmann, D. H. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1653 · Cited by 94
Self-citationNeurofibromatosis 1: closing the GAP between mice and men
Dasgupta, B., & Gutmann, D. H. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00015-1 · Cited by 94
Self-citationMcCarty, M. F. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.01.013 · Cited by 93
Molecular analysis of astrocytomas presenting after age 10 in individuals with NF1
Gutmann, D. H., James, C. D., Pöyhönen, M., Louis, D. N., Ferner, R. E., Guha, A., Hariharan, S., Viskochil, D. H., & Perry, A. (2003) · Neurology · doi:10.1212/wnl.61.10.1397 · Cited by 89
Self-citationIshikawa, H., Takano, M., Matsumoto, N., Sawada, H., Ide, C., Mimura, O., & Dezawa, M. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302277 · Cited by 86
Segmental neurofibromatosis in childhood
Listernick, R., Mancini, A. J., & Charrow, J. (2003) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.20183 · Cited by 86
Self-citationAssociations of clinical features in neurofibromatosis 1 (NF1)
Szudek, J., Birch, P. H., Riccardi, V. M., Evans, D. G., & Friedman, J. M. (2000) · Genetic Epidemiology · Cited by 80
Natural history of neurofibromatosis 1–associated optic nerve glioma in mice
Bajenaru, M. L., Garbow, J. R., Perry, A., Hernandez, M. R., & Gutmann, D. H. (2004) · Annals of Neurology · doi:10.1002/ana.20337 · Cited by 74
Self-citationRescue of axotomized retinal ganglion cells by BDNF gene electroporation in adult rats.
Mo, X., Yokoyama, A., Oshitari, T., Negishi, H., Dezawa, M., Mizota, A., & Adachi‐Usami, E. (2002) · PubMed · Cited by 72
Harnessing preclinical mouse models to inform human clinical cancer trials
Gutmann, D. H., Hunter‐Schaedle, K., & Shannon, K. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28271 · Cited by 72
Self-citationDonovan, S., See, W. L., Bonifas, J. M., Stokoe, D., & Shannon, K. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00214-3 · Cited by 62
Specification of Optic Nerve Oligodendrocyte Precursors by Retinal Ganglion Cell Axons
Gao, L., & Miller, R. H. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0855-06.2006 · Cited by 57
Frazier, J. L., Wang, P. P., Case, D., Tyler, B., Pradilla, G., WEINGART, J. D., & Brem, H. (2003) · Journal of Neuro-Oncology · doi:10.1023/a:1025695423097 · Cited by 48
Caprioli, J., Munemasa, Y., Kwong, J. M. K., & Piri, N. (2009) · PubMed · Cited by 38
Price (1999) · doi:10.1002/1531-8249(199903)45:3
Cited by
Gutmann, D. H., Ferner, R. E., Listernick, R. H., Korf, B. R., Wolters, P. L., & Johnson, K. J. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.4 · Cited by 862
Self-citationWhole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas
the St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project (2013) · Nature Genetics · doi:10.1038/ng.2611 · Cited by 835
Neurofibromatosis Type 1 Revisited
Williams, V. C., Lucas, J., Babcock, M. A., Gutmann, D. H., Korf, B., & Maria, B. L. (2009) · Pediatrics · doi:10.1542/peds.2007-3204 · Cited by 695
Self-citationNeurofibromatosis type 1: a multidisciplinary approach to care
Hirbe, A. C., & Gutmann, D. H. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70063-8 · Cited by 626
Self-citationBRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas
Pfister, S., Janzarik, W. G., Remke, M., Ernst, A., Werft, W., Becker, N., Toedt, G., Wittmann, A., Kratz, C., Olbrich, H., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33656 · Cited by 523
Metadata
- Authors
- Listernick, R., Ferner, R. E., Liu, G. T., & Gutmann, D. H.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2007-03
- Volume
- 61
- Issue
- 3
- Pages
- 189-198
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W1995607634
- Cited by
- 576
- References
- 94
- FWCI
- 17.41
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.